{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:40:06Z","timestamp":1791207606030,"version":"4.1.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Distinct gene expression profiles can be detected in peripheral blood mononuclear cells (PBMCs) in patients with schizophrenia; however, little is known about the effects of antipsychotic medication. This study compared gene expression profiles in PMBCs from treatment-naive patients with schizophrenia before and after antipsychotic drug treatment. PBMCs were obtained from 10 treatment-naive schizophrenia patients before and 6 wk after initiating antipsychotic drug treatment and compared to PMBCs collected from 11 healthy community volunteers. Genome-wide expression profiling was conducted using Illumina HumanHT-12 expression bead arrays and analysed using significance analysis of microarrays. This analysis identified 624 genes with altered expression (208 up-regulated, 416 down-regulated) prior to antipsychotic treatment (p &lt; 0.05) including schizophrenia-associated genes AKT1, DISC1 and DGCR6. After 6\u20138 wk treatment of patients with risperidone or risperidone in combination with haloperidol, only 106 genes were altered, suggesting that the treatment corrected the expression of a large proportion of genes back to control levels. However, 67 genes continued to show the same directional change in expression after treatment. Ingenuity\u00ae pathway analysis and gene set enrichment analysis implicated dysregulation of biological functions and pathways related to inflammation and immunity in patients with schizophrenia. A number of the top canonical pathways dysregulated in treatment-naive patients signal through AKT1 that was up-regulated. After treatment, AKT1 returned to control levels and less dysregulation of these canonical pathways was observed. This study supports immune dysfunction and pathways involving AKT1 in the aetiopathophysiology of schizophrenia and their response to antipsychotic medication.<\/jats:p>","DOI":"10.1017\/s1461145713000035","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T08:21:29Z","timestamp":1361953289000},"page":"1483-1503","source":"Crossref","is-referenced-by-count":65,"title":["Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication"],"prefix":"10.1093","volume":"16","author":[{"given":"Nishantha","family":"Kumarasinghe","sequence":"first","affiliation":[{"name":"University of Sri Jayewardenepura, Nugegoda, Sri Lanka"},{"name":"School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, Australia"},{"name":"Schizophrenia Research Institute, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Beveridge","sequence":"additional","affiliation":[{"name":"Schizophrenia Research Institute, Sydney, Australia"},{"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia"},{"name":"Priority Centre for Translational Neuroscience and Mental Health Research, University of Newcastle, Newcastle, Australia"},{"name":"Hunter Medical Research Institute, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Gardiner","sequence":"additional","affiliation":[{"name":"Schizophrenia Research Institute, Sydney, Australia"},{"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia"},{"name":"Priority Centre for Translational Neuroscience and Mental Health Research, University of Newcastle, Newcastle, Australia"},{"name":"Hunter Medical Research Institute, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Scott","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia"},{"name":"Hunter Medical Research Institute, Newcastle, Australia"},{"name":"Hunter Area Pathology Service, Newcastle NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surangi","family":"Yasawardene","sequence":"additional","affiliation":[{"name":"University of Sri Jayewardenepura, Nugegoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Perera","sequence":"additional","affiliation":[{"name":"University of Sri Jayewardenepura, Nugegoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayan","family":"Mendis","sequence":"additional","affiliation":[{"name":"National Institute of Mental Health, Angoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishka","family":"Suriyakumara","sequence":"additional","affiliation":[{"name":"University of Sri Jayewardenepura, Nugegoda, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Schall","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, Australia"},{"name":"Schizophrenia Research Institute, Sydney, Australia"},{"name":"Priority Centre for Translational Neuroscience and Mental Health Research, University of Newcastle, Newcastle, Australia"},{"name":"Hunter Medical Research Institute, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Tooney","sequence":"additional","affiliation":[{"name":"Schizophrenia Research Institute, Sydney, Australia"},{"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia"},{"name":"Priority Centre for Translational Neuroscience and Mental Health Research, University of Newcastle, Newcastle, Australia"},{"name":"Hunter Medical Research Institute, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"key":"2019101113491134400_ref1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.mp.4001565","article-title":"Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder","volume":"10","author":"Aston","year":"2005","journal-title":"Mol Psychiatry"},{"key":"2019101113491134400_ref2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.neubiorev.2010.10.005","article-title":"Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia","volume":"35","author":"Balu","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"2019101113491134400_ref3","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019101113491134400_ref4","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/mp.2009.84","article-title":"Schizophrenia is associated with an increase in cortical microRNA biogenesis","volume":"15","author":"Beveridge","year":"2010","journal-title":"Mol Psychiatry"},{"key":"2019101113491134400_ref5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1017\/S1461145710000192","article-title":"Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency","volume":"13","author":"Bitanihirwe","year":"2010","journal-title":"Int J Neuropsychopharm"},{"key":"2019101113491134400_ref6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.schres.2005.11.012","article-title":"Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia","volume":"82","author":"Bowden","year":"2006","journal-title":"Schizophr Res"},{"key":"2019101113491134400_ref7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2164-9-199","article-title":"Altered gene expression in the superior temporal gyrus in schizophrenia","volume":"9","author":"Bowden","year":"2008","journal-title":"BMC Genomics"},{"key":"2019101113491134400_refU1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrn3120","article-title":"Linking neurodevelopmental and synaptic theories of mental illness through DISC1","volume":"12","author":"Brandon","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"2019101113491134400_ref8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1017\/S1461145709000315","article-title":"Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia","volume":"12","author":"Bresee","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"2019101113491134400_refU2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.09.003","article-title":"The environment and susceptibility to schizophrenia","volume":"93","author":"Brown","year":"2011","journal-title":"Prog Neurobiol"},{"key":"2019101113491134400_ref9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/archpsyc.55.1.67","article-title":"The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study","volume":"55","author":"Cannon","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113491134400_ref10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/schbul\/sbm007","article-title":"eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?","volume":"33","author":"Carter","year":"2007","journal-title":"Schizophr Bull"},{"key":"2019101113491134400_refU3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0033291705005969","article-title":"The diagnostic interview for psychoses (DIP): development, reliability and applications","volume":"36","author":"Castle","year":"2006","journal-title":"Psychol Med"},{"key":"2019101113491134400_ref11","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1073\/pnas.0804918105","article-title":"The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex","volume":"105","author":"Chen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019101113491134400_refU4","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1371\/journal.pone.0000692","article-title":"Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms","volume":"2","author":"Craddock","year":"2007","journal-title":"PLoS ONE"},{"key":"2019101113491134400_ref12","doi-asserted-by":"publisher","first-page":"e39498","DOI":"10.1371\/journal.pone.0039498","article-title":"A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes","volume":"7","author":"de Jong","year":"2012","journal-title":"PLoS ONE"},{"key":"2019101113491134400_ref13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat Genet"},{"key":"2019101113491134400_ref14","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.110","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","author":"Fillman","year":"2012","journal-title":"Mol Psychiatry"},{"key":"2019101113491134400_ref15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jpsychires.2009.10.011","article-title":"Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia","volume":"44","author":"Garcia-Miss Mdel","year":"2010","journal-title":"J Psychiatr Res"},{"key":"2019101113491134400_ref16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.psychres.2011.08.014","article-title":"Inflammatory markers in antipsychotic-naive patients with nonaffective psychosis and deficit vs. nondeficit features","volume":"198","author":"Garcia-Rizo","year":"2012","journal-title":"Psychiatry Res"},{"key":"2019101113491134400_ref17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/mp.2011.78","article-title":"Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells","volume":"17","author":"Gardiner","year":"2011","journal-title":"Mol Psychiatry"},{"key":"2019101113491134400_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.11.007","article-title":"Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells","author":"Gardiner","year":"2012","journal-title":"J Psychiatr Res"},{"key":"2019101113491134400_ref19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ajmg.b.31239","article-title":"Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives","volume":"156B","author":"Glatt","year":"2011","journal-title":"Am J Med Gen Neuropsych Gen"},{"key":"2019101113491134400_ref20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.pneurobio.2005.10.008","article-title":"N-methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?","volume":"77","author":"Haddad","year":"2005","journal-title":"Prog Neurobiol"},{"key":"2019101113491134400_ref21","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1073\/pnas.081071198","article-title":"Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia","volume":"98","author":"Hakak","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019101113491134400_ref22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/archpsyc.59.7.631","article-title":"Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex","volume":"59","author":"Hemby","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113491134400_ref23","doi-asserted-by":"publisher","first-page":"e4906","DOI":"10.1371\/journal.pone.0004906","article-title":"The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes","volume":"4","author":"Hennah","year":"2009","journal-title":"PLoS ONE"},{"key":"2019101113491134400_ref24","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.mp.4001857","article-title":"Subtyping schizophrenia: implications for genetic research","volume":"11","author":"Jablensky","year":"2006","journal-title":"Mol Psychiatry"},{"key":"2019101113491134400_ref25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1176\/appi.ajp.160.3.425","article-title":"Genetic epidemiology of schizophrenia: phenotypes, risk factors, and reproductive behavior","volume":"160","author":"Jablensky","year":"2003","journal-title":"Am J Psychiatry"},{"key":"2019101113491134400_refU5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/ncb1328","article-title":"A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. [Erratum appears in Nat Cell Biol (2006) 1:100.]","volume":"7","author":"Kamiya","year":"2005","journal-title":"Nat Cell Biol"},{"key":"2019101113491134400_ref26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.neuron.2009.08.008","article-title":"DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"2019101113491134400_ref27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0004867412442405","article-title":"Finding the needle in the haystack: a critical review of microarray gene expression research into schizophrenia","volume":"46","author":"Kumarasinghe","year":"2012","journal-title":"Aust N Z J Psychiatry"},{"key":"2019101113491134400_ref28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1590\/S1516-44462011000300010","article-title":"Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance","volume":"33","author":"Kunz","year":"2011","journal-title":"Rev Bras Psiquiatr"},{"key":"2019101113491134400_ref29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/mp.2009.117","article-title":"Identification of blood biomarkers for psychosis using convergent functional genomics","volume":"16","author":"Kurian","year":"2011","journal-title":"Mol Psychiatry"},{"key":"2019101113491134400_ref30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1423-0127-17-2","article-title":"Genetic copy number variants in sib pairs both affected with schizophrenia","volume":"17","author":"Lee","year":"2010","journal-title":"J Biomed Sci"},{"key":"2019101113491134400_ref31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1086\/376549","article-title":"Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia","volume":"73","author":"Lewis","year":"2003","journal-title":"Am J Hum Genet"},{"key":"2019101113491134400_ref32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11010-011-0911-5","article-title":"Novel human BTB\/POZ domain-containing zinc finger protein ZBTB1 inhibits transcriptional activities of CRE","volume":"357","author":"Liu","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"2019101113491134400_ref33","first-page":"1029","article-title":"Australian Schizophrenia Research Bank: a database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia","volume":"44","author":"Loughland","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"key":"2019101113491134400_ref34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajmg.b.30250","article-title":"Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches","volume":"141","author":"Middleton","year":"2006","journal-title":"Am J Med Gen Neuropsych Gen"},{"key":"2019101113491134400_ref35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0896-6273(00)00085-4","article-title":"Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex","volume":"28","author":"Mirnics","year":"2000","journal-title":"Neuron"},{"key":"2019101113491134400_ref36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pharmthera.2009.06.001","article-title":"Antipsychotic drug actions on gene modulation and signaling mechanisms","volume":"124","author":"Molteni","year":"2009","journal-title":"Pharmacol Ther"},{"key":"2019101113491134400_ref37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"2019101113491134400_ref38","doi-asserted-by":"publisher","first-page":"15873","DOI":"10.1073\/pnas.0903413106","article-title":"DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms","volume":"106","author":"Nakata","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019101113491134400_ref39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00251-006-0178-2","article-title":"Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis","volume":"59","author":"Ota","year":"2007","journal-title":"Immunogenetics"},{"key":"2019101113491134400_ref40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/1742-2094-9-206","article-title":"Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia","volume":"9","author":"Palladino","year":"2012","journal-title":"J Neuroinflammation"},{"key":"2019101113491134400_ref41","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"2019101113491134400_ref42","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"2019101113491134400_ref43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/geno.1998.5480","article-title":"ABC50, a novel human ATP-binding cassette protein found in tumor necrosis factor-alpha-stimulated synoviocytes","volume":"53","author":"Richard","year":"1998","journal-title":"Genomics"},{"key":"2019101113491134400_ref44","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ng.940","article-title":"Genome-wide association study identifies five new schizophrenia loci","volume":"43","author":"Ripke","year":"2011","journal-title":"Nat Genet"},{"key":"2019101113491134400_ref45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coi.2011.12.012","article-title":"Transcriptional drivers of the T-cell lineage program","volume":"24","author":"Rothenberg","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"2019101113491134400_ref46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1176\/appi.ajp.2007.07101573","article-title":"No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics","volume":"165","author":"Sanders","year":"2008","journal-title":"Am J Psychiatry"},{"key":"2019101113491134400_ref47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/nedt.1.2.171.61048","article-title":"Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication","volume":"1","author":"Schmitt","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2019101113491134400_ref48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/15622975.2010.530690","article-title":"Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study","volume":"12","author":"Schmitt","year":"2011","journal-title":"World J Biol Psychiatry"},{"key":"2019101113491134400_ref49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nature08192","article-title":"Common variants on chromosome 6p22.1 are associated with schizophrenia","volume":"460","author":"Shi","year":"2009","journal-title":"Nature"},{"key":"2019101113491134400_ref50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1566-2772(03)00014-8","article-title":"Genetics of schizophrenia: current strategies","volume":"3","author":"Sivagnansundaram","year":"2003","journal-title":"Clin Neurosci Res"},{"key":"2019101113491134400_ref51","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"key":"2019101113491134400_ref52","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019101113491134400_ref53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.b.30272","article-title":"Evaluating the comparability of gene expression in blood and brain","volume":"141","author":"Sullivan","year":"2006","journal-title":"Am J Med Gen Neuropsych Gen"},{"key":"2019101113491134400_ref54","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.schres.2009.12.024","article-title":"Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures","volume":"119","author":"Takahashi","year":"2010","journal-title":"Schizophr Res"},{"key":"2019101113491134400_refU6","doi-asserted-by":"publisher","first-page":"e23691","DOI":"10.1371\/journal.pone.0023691","article-title":"Genome-wide identification of Bcl11b gene targets reveals role in brain-derived neurotrophic factor signaling","volume":"6","author":"Tang","year":"2011","journal-title":"PLoS ONE"},{"key":"2019101113491134400_ref55","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.biopsych.2007.06.005","article-title":"AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families","volume":"63","author":"Thiselton","year":"2008","journal-title":"Biol Psychiatry"},{"key":"2019101113491134400_ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.b.30161","article-title":"Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report","volume":"133B","author":"Tsuang","year":"2005","journal-title":"Am J Med Gen Neuropsych Gen"},{"key":"2019101113491134400_ref57","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019101113491134400_ref58","doi-asserted-by":"publisher","first-page":"e32618","DOI":"10.1371\/journal.pone.0032618","article-title":"marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients","volume":"7","author":"van Beveren","year":"2012","journal-title":"PLoS ONE"},{"key":"2019101113491134400_ref59","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neulet.2008.11.051","article-title":"Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK","volume":"450","author":"Wang","year":"2009","journal-title":"Neurosci Lett"},{"key":"2019101113491134400_ref60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.mcn.2005.09.013","article-title":"Altered gene expression in the amygdala in schizophrenia: up-regulation of genes located in the cytomatrix active zone","volume":"31","author":"Weidenhofer","year":"2006","journal-title":"Mol Cell Neurosci"},{"key":"2019101113491134400_refU7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psychiatr"},{"key":"2019101113491134400_ref61","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jpsychires.2012.04.026","article-title":"Elevated interleukin-18 serum levels in chronic schizophrenia: association with psychopathology","volume":"46","author":"Xiu","year":"2012","journal-title":"J Psychiatr Res"},{"key":"2019101113491134400_ref62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.schres.2010.02.1031","article-title":"Convergent evidence shows a positive association of interleukin-1 gene complex locus with susceptibility to schizophrenia in the Caucasian population","volume":"120","author":"Xu","year":"2010","journal-title":"Schizophr Res"},{"key":"2019101113491134400_ref63","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4088\/JCP.v65n0710","article-title":"Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia","volume":"65","author":"Zhang","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2019101113491134400_ref64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1155\/2005\/275318","article-title":"Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers","volume":"21","author":"Zvara","year":"2005","journal-title":"Dis Markers"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/7\/1483\/30135425\/16-7-1483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/7\/1483\/30135425\/16-7-1483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T20:49:15Z","timestamp":1570826955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/16\/7\/1483\/712477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.1017\/s1461145713000035","relation":{},"ISSN":["1469-5111","1461-1457"],"issn-type":[{"value":"1469-5111","type":"electronic"},{"value":"1461-1457","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,8]]},"published":{"date-parts":[[2013,8,1]]}}}